{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-002339","form_type":"8-K","ticker":"CERO","cik":"0001870404","company_name":"CERO THERAPEUTICS HOLDINGS, INC.","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.428053+00:00","generated_at":"2026-05-28T05:40:26.071982+00:00","sec_items":["3.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CERO Therapeutics issues 16.4M shares and warrants upon warrant exercise for $500K","bullets":["Holder exercised 625 Preferred Warrants at $800/sh, paying $500K (20% OID on $625K stated value).","Series A Preferred shares converted into 16,385,275 common shares of CERO.","Company issued new warrants to purchase 16,385,275 common shares at $0.0582/sh (Jan 3 closing price).","Proceeds included in previously reported cash balance as of Jan 7, 2025; exemption under Section 4(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-002339","json":"https://secwatch.observer/filing/0001213900-25-002339.json","markdown":"https://secwatch.observer/filing/0001213900-25-002339.md","text":"https://secwatch.observer/filing/0001213900-25-002339.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870404/000121390025002339/0001213900-25-002339-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870404/000121390025002339/ea0227335-8k_cerotherap.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T05:40:26.071982+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}